Best Assessment of Sore Throat and Antibiotic Prescribing

ConditionPharyngitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6+
SponsorVastra Gotaland Region

About this trial

This project aims to investigate if an organisational change of patient flow away from medical practitioners can reduce unnecessary antibiotic prescribing in patients attending with a sore throat as the main complaint.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The patient is contacting/attending PHC centre or Pharmacy presenting with a sore throat as the main complaint.

Male or female, aged ≥6 years.

Fluent in Swedish (reading, writing, conversational) (applicable to caregivers/parents/guardians in case of children).

Mental state such that he or she can understand and give informed consent to participation in the study by signing the Information and Consent Form.

Disqualifiers

The illness episode is classified as potentially complicated or potentially critically ill

Presence of SARS-CoV-2 virus in a patient first appearing at the PHC in a cluster where the assessment is supposed to be done by the pharmacists. The patient will not be sent to the pharmacist in case of presence of SARS-CoV-2-virus.

Patient request to be withdrawn from the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Physicians assess patients

    Behavioral

    Physicians are asked to assess patients following the current Swedish guideline

  • Nurses assess patients

    Behavioral

    Nurses are asked to assess patients following the current Swedish guideline

  • Pharmacists assess patients

    Behavioral

    Pharmacists are asked to assess patients following the current Swedish guideline

Treatment groups

450 Participants
are divided into 3 treatment groups
Group A: Initial assessement by physiciansActive comparator 1 intervention
Group B: Initial assessement by nursesActive comparator 1 intervention
Group C: Initial assessement by pharmacistsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Guideline adherence

Will the proportion of patients attending for an uncomplicated acute sore throat being managed according to prevailing guidelines differ if the initial assessment is made by a medical practitioner, a trained nurse or a trained pharmacist

Time frame
Immediately after the consultation

Secondary outcomes

1

Illness severity

What proportion of patients attending PHC centres or pharmacies are classified as apparently uncomplicated, potentially complicated or potentially critically ill

Time frame
Immediately after the consultation
2

Type of patients seeking care

Will patient characteristics differ if the patient first appears to the medical practitioner, a trained nurse or a trained pharmacist?

Time frame
Immediately after the consultation
3

Presence of SARS-CoV-2 virus

To what extent do patients attending Primary Health Care/Pharmacies due to an acute sore throat harbour the SARS-CoV-2 virus?

Time frame
Immediately after the consultation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vastra Gotaland Region

Lead sponsor

Göteborg University

Collaborator